Related references
Note: Only part of the references are listed.Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism
Mareike Lankeit et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Gene expression pattern in biomechanically stretched cardiomyocytes - Evidence for a stretch-specific gene program
Derk Frank et al.
HYPERTENSION (2008)
Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction
Tibor Kempf et al.
EUROPEAN HEART JOURNAL (2007)
Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure
Tibor Kempf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
ACC/AHA 2007 Guidelines for the Management of Patients With unstable Angina/Non-ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
Jeffrey L. Anderson et al.
CIRCULATION (2007)
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay
Tibor Kempf et al.
CLINICAL CHEMISTRY (2007)
Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension
Anna Fijalkowska et al.
CHEST (2006)
The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury
T Kempf et al.
CIRCULATION RESEARCH (2006)
GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation
J Xu et al.
CIRCULATION RESEARCH (2006)
Growth differentiation factor-15: Induction in liver injury through p53 and tumor necrosis factor-independent mechanisms
TA Zimmers et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Goal-oriented treatment and combination therapy for pulmonary arterial hypertension
MM Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
A gene atlas of the mouse and human protein-encoding transcriptomes
AI Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Drug therapy: Treatment of pulmonary arterial hypertension
M Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions
D Schlittenhardt et al.
CELL AND TISSUE RESEARCH (2004)
Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging
SD Anker et al.
CIRCULATION (2003)
Characterization of growth-differentiation factor 15, a transforming growth factor β superfamily member induced following liver injury
EC Hsiao et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
